Lenvatinib, a molecule with versatile application: from preclinical evidence to future development in anti-cancer treatment

Lenvatinib is an emerging multi-kinase inhibitor with a preferential anti-angiogenic activity, which has shown efficacy in the treatment of renal cell carcinoma, differentiated thyroid cancer and hepatocellular carcinoma. It inhibits vascular endothelial growth factor receptor family (VEGFR1–3), fib...

Descripción completa

Detalles Bibliográficos
Autores principales: Capozzi, Monica, De Divitiis, Chiara, Ottaiano, Alessandro, von Arx, Claudia, Scala, Stefania, Tatangelo, Fabiana, Delrio, Paolo, Tafuto, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502442/
https://www.ncbi.nlm.nih.gov/pubmed/31118801
http://dx.doi.org/10.2147/CMAR.S188316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502442/
https://www.ncbi.nlm.nih.gov/pubmed/31118801
http://dx.doi.org/10.2147/CMAR.S188316

Ejemplares similares